S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
TSE:VNP

5N Plus (VNP) Stock Price, News & Analysis

C$4.64
-0.13 (-2.73%)
(As of 04/19/2024 ET)
Today's Range
C$4.54
C$4.82
50-Day Range
C$4.17
C$5.00
52-Week Range
C$2.86
C$5.13
Volume
60,290 shs
Average Volume
104,853 shs
Market Capitalization
C$411.99 million
P/E Ratio
20.17
Dividend Yield
2.25%
Price Target
C$5.33

5N Plus MarketRank™ Stock Analysis

Analyst Rating
Strong Buy
3.50 Rating Score
Upside/​Downside
14.9% Upside
C$5.33 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.04mentions of 5N Plus in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
C$312,032 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.27 out of 5 stars

VNP stock logo

About 5N Plus Stock (TSE:VNP)

5N Plus Inc. produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells. It also provides active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial application markets. 5N Plus Inc. is headquartered in Montreal, Canada.

VNP Stock Price History

VNP Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
5N Plus: Top 10 Undervalued Chemicals Industry Stocks (VNP)
PLUS Loan: Meaning, Pros and Cons, Repaying
Closing Bell: 5N Plus Inc flat on Friday (VNP)
3 Stocks Powering the Green Economy
Estimating The Fair Value Of 5N Plus Inc. (TSE:VNP)
5N Plus Solar Cells Powering Chandrayaan-3
Closing Bell: 5N Plus Inc up on Monday (VNP)
See More Headlines
Receive VNP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 5N Plus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/20/2024
Next Earnings (Estimated)
5/01/2024

Industry, Sector and Symbol

Industry
Specialty Chemicals
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
780
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$5.33
High Stock Price Target
C$6.00
Low Stock Price Target
C$4.75
Potential Upside/Downside
+14.9%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

P/E Growth
6283.33
Net Income
C$15.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$242.37 million
Cash Flow
C$0.75 per share
Book Value
C$1.45 per share

Miscellaneous

Free Float
N/A
Market Cap
C$411.99 million
Optionable
Not Optionable
Beta
1.64
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

VNP Stock Analysis - Frequently Asked Questions

Should I buy or sell 5N Plus stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 5N Plus in the last year. There are currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" VNP shares.
View VNP analyst ratings
or view top-rated stocks.

What is 5N Plus' stock price target for 2024?

2 Wall Street research analysts have issued 1 year target prices for 5N Plus' stock. Their VNP share price targets range from C$4.75 to C$6.00. On average, they anticipate the company's stock price to reach C$5.33 in the next year. This suggests a possible upside of 14.9% from the stock's current price.
View analysts price targets for VNP
or view top-rated stocks among Wall Street analysts.

How have VNP shares performed in 2024?

5N Plus' stock was trading at C$3.78 at the beginning of 2024. Since then, VNP stock has increased by 22.8% and is now trading at C$4.64.
View the best growth stocks for 2024 here
.

When is 5N Plus' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our VNP earnings forecast
.

How were 5N Plus' earnings last quarter?

5N Plus Inc. (TSE:VNP) issued its earnings results on Tuesday, February, 27th. The company reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by $0.02. The firm had revenue of $88.59 million for the quarter, compared to the consensus estimate of $84.15 million. 5N Plus had a net margin of 6.35% and a trailing twelve-month return on equity of 12.76%.

What other stocks do shareholders of 5N Plus own?
How do I buy shares of 5N Plus?

Shares of VNP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:VNP) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners